Key result
The Angiotensin II type 2 (AT2) receptor and its novel nonpeptide selective ligands show potential utility in improving impaired cognitive performance and regulating appetite and metabolic disorders.
This review highlights the potential role of the AT2 receptor in cognitive function, neurological disorders, and metabolic regulation, suggesting utility for novel nonpeptide selective AT2 receptor ligands.
May support AT2 ligands for cognition and metabolism; hypothesis-generating and requires prospective trials before any clinical consideration.
Angiotensin II (Ang II) is the main active product of the renin-angiotensin system (RAS), mediating its action via two major receptors, namely, the Ang II type 1 (AT(1)) receptor and the type 2 (AT(2)) receptor. Recent results also implicate several other members of the renin-angiotensin system in various aspects of brain functions. The first aim of this paper is to summarize the current state of knowledge regarding the properties and signaling of the AT(2) receptor, its expression in the brain, and its well-established effects. Secondly, we will highlight the potential role of the AT(2) receptor in cognitive function, neurological disorders and in the regulation of appetite and the possible link with development of metabolic disorders. The potential utility of novel nonpeptide selective AT(2) receptor ligands in clarifying potential roles of this receptor in physiology will also be discussed. If confirmed, these new pharmacological tools should help to improve impaired cognitive performance, not only through its action on brain microcirculation and inflammation, but also through more specific effects on neurons. However, the overall physiological relevance of the AT(2) receptor in the brain must also consider the Ang IV/AT(4) receptor.
No takes yet. Share an insight, caveat, or question.
Guimond et al. (2012) conducted a review in Neurological disorders and cognitive function. Angiotensin II Type 2 (AT2) Receptor was evaluated. The Angiotensin II type 2 (AT2) receptor and its novel nonpeptide selective ligands show potential utility in improving impaired cognitive performance and regulating appetite and metabolic disorders.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: